Initial Testing (Stage 1) of LCL161, a SMAC Mimetic, by the Pediatric Preclinical Testing Program

LCL161, a SMAC mimetic, was tested against the PPTP in vitro panel (1.0 nM to 10.0 μM) and the PPTP in vivo panels (30 mg/kg or 75 mg/kg [solid tumors] or 100 mg/kg [ALL]) administered orally twice weekly. LCL161 showed a median relative IC(50) value of >10 μM, being more potent against several l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Houghton, Peter J., Kang, Min H., Reynolds, C. Patrick, Morton, Christopher L., Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Carol, Hernan, Lock, Richard, Maris, John M., Billups, Catherine A., Smith, Malcolm A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3253328/
https://ncbi.nlm.nih.gov/pubmed/21681929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23167
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia